Uncovering Resilience to Alzheimer's Disease
A recent publication highlights the discovery of the second case demonstrating exceptional resilience to autosomal dominant Alzheimer's disease (ADAD). This male patient, carrying a PSEN1-E280A mutation, remained cognitively intact until the age of 67, despite the presence of highly elevated amyloid plaque burden. Interestingly, the patient did not possess the protective APOE3 Christchurch variant but instead had a rare variant in the RELN gene (H3447R), termed COLBOS. This gain-of-function variant showed enhanced ability to activate its protein target Dab1, leading to reduced human Tau phosphorylation. These findings suggest a potential role for RELN signaling in resilience to dementia, highlighting the importance of genetic variants in ADAD protection. The apolipoprotein E (APOE) gene, specifically the APOE ε4 allele, is the most well-established genetic risk factor for late-onset Alzheimer's disease. Inheriting one or two copies of the APOE ε4 allele increases the risk of d